iCo Therapeutics Inc (OTCMKTS:ICOTF) was down 19.6% on Wednesday . The company traded as low as $0.04 and last traded at $0.04. Approximately 15,000 shares were traded during trading, an increase of 922% from the average daily volume of 1,468 shares. The stock had previously closed at $0.05.

About iCo Therapeutics (OTCMKTS:ICOTF)

iCo Therapeutics Inc, a biotechnology company, focuses on the identification, development, and commercialization of drug candidates to treat sight and life threatening diseases. Its in-licensed product candidates include iCo-008, a human monoclonal antibody, which is in Phase II clinical trial to treat sight threatening ocular allergies and various systemic disease indications; and Oral AmpB Delivery System that is in pre-clinical stage used for the treatment of systemic fungal infections.

Featured Story: What are no-load funds?

Receive News & Ratings for iCo Therapeutics Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for iCo Therapeutics and related companies with MarketBeat.com’s FREE daily email newsletter.


READ  ICO News: Delay ICO until proper regulation passes, urges Malaysian lawmaker


Please enter your comment!
Please enter your name here